Showing results (651-660 of 1,043) with videos related to
Sort By:
Pageof 105
Cell Host & Microbe|November 5, 2020
Accelerated Preclinical Paths to Support Rapid Development of COVID-19 TherapeuticsJay A Grobler, Annaliesa S Anderson, Prabhavathi Fernandes, et al.Journal of Virology|October 16, 2015
Interferon-Regulatory Factor 5-Dependent Signaling Restricts Orthobunyavirus Dissemination to the Central Nervous SystemJose Luiz Proenca-Modena, Jennifer L Hyde, Renata Sesti-Costa, et al.Neuro-Oncology|February 23, 2026
Oncolytic Zika virus therapy leverages CCR2+ monocytes to boost anti-glioblastoma T cell responsesKevin S Cashman, Akshitkumar M Mistry, Ashwani Kesarwani, et al.Mbio|September 17, 2015
Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus InfectionAmelia K Pinto, James D Brien, Chia-Ying Kao Lam, et al.Cell Reports|September 5, 2019
Expression of the Mxra8 Receptor Promotes Alphavirus Infection and Pathogenesis in Mice and DrosophilaRong Zhang, James T Earnest, Arthur S Kim, et al.Journal of Virology|August 24, 2007
Identification of novel small-molecule inhibitors of West Nile virus infectionAmine O Noueiry, Paul D Olivo, Urszula Slomczynska, et al.Virology|March 8, 2005
An infectious West Nile virus that expresses a GFP reporter geneTheodore C Pierson, Michael S Diamond, Asim A Ahmed, et al.Journal of Virology|July 7, 2018
Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in MiceJulia C Frei, Ariel S Wirchnianski, Jennifer Govero, et al.The Journal of Infectious Diseases|October 17, 2019
Zika Virus Causes Acute and Chronic Prostatitis in Mice and MacaquesJacques Halabi, Brett W Jagger, Vanessa Salazar, et al.Antimicrobial Agents and Chemotherapy|April 25, 2007
Defining limits of treatment with humanized neutralizing monoclonal antibody for West Nile virus neurological infection in a hamster modelJohn D Morrey, Venkatraman Siddharthan, Aaron L Olsen, et al.Pageof 105